An open-label, multi centre, phase II, non-comparative trial of ZD1839 monotherapy in chemotherapy-naive patients with stage IV or stage III non-operable non-small cell lung cancer (NSCLC)
Year: 2005
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: M. Reck, U. Gatzemeier, E. Bucholz, C. G. Gahlemann, C. Manegold
Institution: AstraZeneca (Germany)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2286730948